COMPOUND WITH CONFIDENCE: PCCA Membership, $795/month.

Pharmacy compounding's source for clinical information, regulatory updates, and opportunities

THE PCCA BLOG

rss

Stay current on PCCA news and events, market trends, and all things compounding!

2_Potential_Alternatives_to_Dichloralphenazone.jpg

Matt Martin of PCCA Clinical Services and Melissa Merrell Rhoads, Director of Formulation development discuss two possible alternatives to Dichloralphenazone for compounding pharmacists.